Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
2002 1
2003 3
2004 4
2005 2
2006 8
2007 4
2008 3
2009 7
2010 5
2011 1
2012 4
2013 6
2014 3
2015 14
2016 12
2017 15
2018 14
2019 9
2020 13
2021 14
2022 10
2023 16
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

158 results

Results by year

Filters applied: . Clear all
Page 1
Multiple sclerosis.
Jakimovski D, Bittner S, Zivadinov R, Morrow SA, Benedict RH, Zipp F, Weinstock-Guttman B. Jakimovski D, et al. Among authors: morrow sa. Lancet. 2024 Jan 13;403(10422):183-202. doi: 10.1016/S0140-6736(23)01473-3. Epub 2023 Nov 7. Lancet. 2024. PMID: 37949093 Review.
Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group Recommendations.
Freedman MS, Devonshire V, Duquette P, Giacomini PS, Giuliani F, Levin MC, Montalban X, Morrow SA, Oh J, Rotstein D, Yeh EA; Canadian MS Working Group. Freedman MS, et al. Among authors: morrow sa. Can J Neurol Sci. 2020 Jul;47(4):437-455. doi: 10.1017/cjn.2020.66. Epub 2020 Apr 6. Can J Neurol Sci. 2020. PMID: 32654681 Review.
Use of natalizumab in persons with multiple sclerosis: 2022 update.
Morrow SA, Clift F, Devonshire V, Lapointe E, Schneider R, Stefanelli M, Vosoughi R. Morrow SA, et al. Mult Scler Relat Disord. 2022 Sep;65:103995. doi: 10.1016/j.msard.2022.103995. Epub 2022 Jun 26. Mult Scler Relat Disord. 2022. PMID: 35810718 Free article. Review.
Ambroxol as a novel disease-modifying treatment for Parkinson's disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial.
Silveira CRA, MacKinley J, Coleman K, Li Z, Finger E, Bartha R, Morrow SA, Wells J, Borrie M, Tirona RG, Rupar CA, Zou G, Hegele RA, Mahuran D, MacDonald P, Jenkins ME, Jog M, Pasternak SH. Silveira CRA, et al. Among authors: morrow sa. BMC Neurol. 2019 Feb 9;19(1):20. doi: 10.1186/s12883-019-1252-3. BMC Neurol. 2019. PMID: 30738426 Free PMC article. Clinical Trial.
Autonomic dysfunction in multiple sclerosis.
Racosta JM, Kimpinski K, Morrow SA, Kremenchutzky M. Racosta JM, et al. Among authors: morrow sa. Auton Neurosci. 2015 Dec;193:1-6. doi: 10.1016/j.autneu.2015.06.001. Epub 2015 Jun 7. Auton Neurosci. 2015. PMID: 26070809 Review.
Cardiovascular autonomic dysfunction in multiple sclerosis: a meta-analysis.
Racosta JM, Sposato LA, Morrow SA, Cipriano L, Kimpinski K, Kremenchutzky M. Racosta JM, et al. Among authors: morrow sa. Mult Scler Relat Disord. 2015 Mar;4(2):104-11. doi: 10.1016/j.msard.2015.02.002. Epub 2015 Feb 23. Mult Scler Relat Disord. 2015. PMID: 25787186 Review.
158 results